CorrlensCorrlens
Correlate

Correlation Analysis

JPMorgan Chase & Co. vs Regeneron Pharmaceuticals Inc

JPM vs REGN

-0.008

Near-zero inverse

When one moves up, the other tends to move down.

JPM logo

JPMorgan Chase & Co.

JPM

JPMorgan Chase is one of the largest and most complex financial institutions in the United States, with more than $4.4 trillion in assets. It is organized into four major segments: consumer and community banking, corporate and investment banking, commercial banking, and asset and wealth management. JPMorgan operates and is subject to regulation in multiple countries.

Market cap 792.5B

REGN logo

Regeneron Pharmaceuticals Inc

REGN

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has early-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).

Market cap 80.7B · 15,410 employees

Apr 9, 2021 — Apr 7, 2026Daily1,254 data pointsStockStockFinancialsHealthcare

Time Series

Relative Performance

Green: JPMGray: REGN36 of 1,254 points (sampled)

Who Moves First

JPM leads REGN by 6 days

JPM tends to move before REGN.

After testing 13 timing shifts, the strongest relationship was -0.018 (they moved in opposite directions).

Do They Crash Together?

Correlation by Market Regime

How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.

Both Rising

-0.361

15 periods · Return correlation when both series rose

Both Falling

+0.740

6 periods · Return correlation when both series fell

Diverging

-0.487

14 periods · Return correlation when series moved apart

R-Squared

0.0%

Share of variance in one series explained by the other.

Trend Agreement

60.2%

How often both series moved in the same direction period-to-period.

Overlap Quality

1,254

Deep shared window — 1,254 usable pairs.

Significance

n.s.

95% CI: [-0.063, 0.048]

Scatter

XY Regression

98.3100150200250300333.44226008001,0001,198JPMorgan Chase & Co.Regeneron Pharmaceuticals IncData pointsFit (r = -0.008)

Pipeline

Data quality details

Pipeline Summary

1,254 paired data points survived the daily window.

Raw input

1,254

1,254

Normalized

1,254

1,254

Prepared

1,254

1,254

Aligned

1,254

1,254

Invalid removed

0

A: 0 / B: 0

Duplicates removed

0

A: 0 / B: 0

Alignment drops

0

A: 0 / B: 0

Series A

JPM logo

JPMorgan Chase & Co.

JPM

Market cap 792.5B

Stock · 1,254 raw → 1,254 prepared

Series B

REGN logo

Regeneron Pharmaceuticals Inc

REGN

Market cap 80.7B · 15,410 employees

Stock · 1,254 raw → 1,254 prepared

Sign agreement

100.0%

How often both values share the same sign.

Zero crossings

12

Estimated crossover points between normalized spreads.

Slope

-0.0189

Linear regression slope.

Intercept

737.3722

Linear regression intercept.

Related Extremes

Highest and Lowest Correlated

Saved 7 hours ago · ID: stock-jpm-vs-stock-regn-daily